Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 18, 2020 | CANbridge Pharmaceuticals | $98.0M Series D | Lefei Sun, WuXi AppTec | Hudson Bay Capital, Derek DiRocco, Tigermed |
| Jul 18, 2018 | Ascentage Pharma | $150.0M Series C | Teng Yue Partners, Lawrence Tian | ArrowMark Partners, CCB International, CTS Capital, HDY International Investment |